Overview
Classic paraneoplastic limbic encephalitis (PLE) is a rare neurological condition classified as a paraneoplastic neurological syndrome, meaning it arises as an immune-mediated complication of an underlying cancer rather than from direct tumor invasion of the nervous system. This Orphanet entry (163898) is marked as OBSOLETE, indicating it has been reclassified or merged into broader categories of autoimmune or paraneoplastic encephalitis in current nosology. The condition primarily affects the limbic system of the brain, including the hippocampus, amygdala, and related structures, leading to prominent neuropsychiatric symptoms. Key clinical features of classic paraneoplastic limbic encephalitis include subacute onset of short-term memory loss, confusion, seizures, psychiatric disturbances (such as anxiety, depression, hallucinations, and personality changes), and sleep disturbances. The condition is most commonly associated with antibodies directed against intracellular neuronal antigens, particularly anti-Hu (ANNA-1), anti-Ma2/Ta, and anti-CV2/CRMP5 antibodies. Cancers most frequently implicated include small cell lung cancer, testicular germ cell tumors, breast cancer, and thymoma. Diagnosis relies on clinical presentation, detection of onconeural antibodies, brain MRI showing T2/FLAIR signal abnormalities in the medial temporal lobes, and identification of the underlying malignancy. Treatment focuses on addressing the underlying cancer, as tumor removal or reduction can sometimes lead to neurological stabilization or improvement. Immunotherapy, including corticosteroids, intravenous immunoglobulin (IVIg), plasma exchange, rituximab, or cyclophosphamide, is used to modulate the immune response. However, prognosis in classic PLE associated with intracellular antibodies is often guarded, as neurological deficits may be partially irreversible due to neuronal damage. Early diagnosis and treatment of the underlying malignancy remain the most important prognostic factors.
Also known as:
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Classic paraneoplastic limbic encephalitis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Classic paraneoplastic limbic encephalitis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Classic paraneoplastic limbic encephalitis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Classic paraneoplastic limbic encephalitis.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Classic paraneoplastic limbic encephalitis.
Start the conversation →Latest news about OBSOLETE: Classic paraneoplastic limbic encephalitis
No recent news articles for OBSOLETE: Classic paraneoplastic limbic encephalitis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Classic paraneoplastic limbic encephalitis
What is OBSOLETE: Classic paraneoplastic limbic encephalitis?
Classic paraneoplastic limbic encephalitis (PLE) is a rare neurological condition classified as a paraneoplastic neurological syndrome, meaning it arises as an immune-mediated complication of an underlying cancer rather than from direct tumor invasion of the nervous system. This Orphanet entry (163898) is marked as OBSOLETE, indicating it has been reclassified or merged into broader categories of autoimmune or paraneoplastic encephalitis in current nosology. The condition primarily affects the limbic system of the brain, including the hippocampus, amygdala, and related structures, leading to p
At what age does OBSOLETE: Classic paraneoplastic limbic encephalitis typically begin?
Typical onset of OBSOLETE: Classic paraneoplastic limbic encephalitis is adult. Age of onset can vary across affected individuals.